Cyclin-dependent kinase inhibitors: efficacy and safety

Ngā tūemi rite

• Cyclin-dependent kinase inhibitors: efficacy and safety
  mā: I. B. Kononenko, me ētahi atu.
  I whakaputaina: (2019-06-01)
• Locoregional Radiotherapy in Patients with Advanced Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors Based on Real-World Data
  mā: Marcin Kubeczko, me ētahi atu.
  I whakaputaina: (2024-07-01)
• Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis
  mā: Marcin Kubeczko, me ētahi atu.
  I whakaputaina: (2024-06-01)
• A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer
  mā: Pin Zhang, me ētahi atu.
  I whakaputaina: (2021-04-01)
• Induction of apoptosis in cancer cells by tumor necrosis factor and butyrolactone, an inhibitor of cyclin-dependent kinases
  mā: J.E. Belizário, me ētahi atu.
  I whakaputaina: (1999-04-01)